Anti-ACVR2A & ACVR2B重组抗体|科研级 Bimagrumab ( 比玛卢单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-ACVR2A & ACVR2B重组抗体|科研级 Bimagrumab ( 比玛卢单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-ACVR2A & ACVR2B重组抗体|科研级 Bimagrumab ( 比玛卢单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1301

Alias

科研级 Bimagrumab ( 比玛卢单抗 ), Anti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab

Molecular Name

Bimagrumab

Size

1mg, 5mg

CAS Number

1356922-05-8

Isotype

IgG1 Lambda

Clonality

Monoclonal

Concentration

1mg/ml

Applications

FC, IP, ELISA, Neut, FuncS, IF, ICC, MRI

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

ACVR2A/ACVR2B[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013, it was announced that bimagrumab had received a breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by the US Food and Drug Administration.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ